Skip to main content
. 2017 May 4;2017:3761292. doi: 10.1155/2017/3761292

Table 1.

Clinical features of patients.

Patient Gender Age at diagnosis Tumor site NF status Initial path Grade Cycles of
chemo
Decrease in tumor (%) Final path Clinical status Overall
survival
(months)
Patient 1 M 59 Axilla Yes Neuroepithelial differentiation of MPNST Unable to review 5 47 Residual fibroadipose tissue and metastatic sarcoma in 3/12 lymph nodes NED 36

Patient 2 M 27 Mediastinum Yes MPNST FNCLCC Grade 2 11 39 MPNST and areas of lung with pneumocyte hyperplasia Deceased 14

Patient 3 M 29 RP No MPNST FNCLCC Grade 3 6 15 MPNST with 80% treatment effect NED 42

Patient 4 F 54 Brachial plexus No MPNST FNCLCC Grade 2 5 33 CR without surgery NED 43

Patient 5 M 35 Neck Yes MPNST FNCLCC
Grade 3
5 0 MPNST with 20% treatment effect NED 9

RP = retroperitoneum.